Dr Reddys Laboratories announced that the United States Food & Drug Administration (USFDA) completed a GMP inspection at its API Middleburgh facility in New York. The inspection was conducted from 12th May, 2025 to 16th May, 2025 (US EST time). The company has been issued a Form 483 with 2 observations.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
